Drug Enforcement Administration November 2013 – Federal Register Recent Federal Regulation Documents

Zizhuang Li, M.D.; Decision and Order
Document Number: 2013-28525
Type: Notice
Date: 2013-11-29
Agency: Drug Enforcement Administration, Department of Justice
Wheatland Pharmacy; Decision and Order
Document Number: 2013-27700
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; GE Healthcare
Document Number: 2013-27661
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Mylan Pharmaceuticals, Inc.
Document Number: 2013-27660
Type: Notice
Date: 2013-11-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Morton Grove Pharmaceuticals
Document Number: 2013-27490
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey, Inc.
Document Number: 2013-27488
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Apertus Pharmaceuticals
Document Number: 2013-27487
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration: AMPAC Fine Chemicals, LLC.
Document Number: 2013-27484
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Johnson Matthey, Inc.
Document Number: 2013-27483
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Catalent CTS, LLC
Document Number: 2013-27482
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Chattem Chemicals, Inc.
Document Number: 2013-27481
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Noramco, Inc.
Document Number: 2013-27457
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application; Cerilliant Corporation
Document Number: 2013-27454
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application: Johnson Matthey, Inc.
Document Number: 2013-27448
Type: Notice
Date: 2013-11-18
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Phenethylamines Into Schedule I
Document Number: 2013-27315
Type: Rule
Date: 2013-11-15
Agency: Drug Enforcement Administration, Department of Justice
The Deputy Administrator of the Drug Enforcement Administration (DEA) is issuing this final order to temporarily schedule three synthetic phenethylamines into the Controlled Substances Act (CSA) pursuant to the temporary scheduling provisions of 21 U.S.C. 811(h). The substances are 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5), 2-(4- chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82), and 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36) [hereinafter 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe]. This action is based on a finding by the Deputy Administrator that the placement of these synthetic phenethylamines and their optical, positional, and geometric isomers, salts and salts of isomers in schedule I of the CSA is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, and possess), or propose to handle these synthetic phenethylamines.
Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV
Document Number: 2013-25933
Type: Proposed Rule
Date: 2013-11-04
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to place the substance 2-((dimethylamino)methyl)-1-(3- methoxyphenyl)cyclohexanol, its salts, isomers, salts of isomers, and all isomeric configurations of possible forms including tramadol (the term ``isomers'' includes the optical and geometric isomers) into Schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (HHS) and an evaluation of all other relevant data by the DEA. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to Schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle tramadol.